CellMax Life
PrivateLast Round
Series C
Mar 23, 2021
Est. Valuation
$14M
Total Funding Raised
$9.76M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CellMax Life operates in Healthcare & Life Sciences and is based in Sunnyvale, California. Its latest recorded funding round was a Series C round in March 2021.
CellMax Life is a biotechnology company that develops non-invasive blood tests for early cancer detection and screening.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellMax Life Comparables
Compare CellMax Life with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Epic Sciences | 81% | |
| Datar Cancer Genetics | 81% | |
| DiaCarta, Inc. | 80% |
For institutional investors. Book with your work email.
CellMax Life Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 23, 2021 | ||||
| Grant | Jun 14, 2017 | ||||
| Series A Extension | Jul 26, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
CellMax Life Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aflac Ventures | Series C |
| Artiman | Series C, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 45% MoM, from 1.2K to 1.8K.
- Jul 26, 2016
$9M round led by Artiman
For institutional investors. Book with your work email.
CellMax Life Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CellMax Life's valuation, stock price, and market status.
Is CellMax Life a public or private company?
CellMax Life is a private company.
What is the current stock price of CellMax Life?
CellMax Life is a private company, so its shares have no public market price. Caplight tracks CellMax Life's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CellMax Life worth (valuation)?
CellMax Life's valuation is estimated at $14.0M based on funding round data.
Can I buy CellMax Life stock?
CellMax Life shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CellMax Life's last funding round?
CellMax Life's most recent funding round was Series C on March 23, 2021.
Who are the main investors in CellMax Life?
Key investors in CellMax Life include Artiman.
Will CellMax Life IPO soon?
No public IPO plans have been announced for CellMax Life.
How can I track CellMax Life secondary market activity?
Caplight tracks bids, offers, and trades in CellMax Life's shares on secondary markets.